arrow_back Trending Legislation
Share share

Mandatory Gluten Labeling for Medicines: Enhanced Transparency for Patients.

New regulations mandate that labels on human-use drugs clearly disclose the presence of ingredients derived from gluten-containing grains. This will allow individuals with gluten intolerance or celiac disease to choose medications more safely, avoiding adverse reactions. The act aims to enhance patient safety and awareness.
Key points
Drugs containing gluten must clearly state this on their labels.
The label must identify the specific gluten-containing grain (e.g., wheat, barley, rye) from which the ingredient is derived.
The rules will take effect no later than two years after enactment, or sooner if determined by the Secretary of Health and Human Services.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Gluten in Medicine Disclosure Act of 2021
Print number: HR 2435
Sponsor: Rep. Ryan, Tim [D-OH-13]
Process start date: 2021-04-08